期刊文献+

胶质瘤细胞GDNF基因启动子Ⅰ区甲基化水平对其基因转录的影响 被引量:2

Effect of methylation levels of GDNF gene promoter Ⅰ region on its transcription in glioma U251 cells
下载PDF
导出
摘要 目的探讨胶质瘤细胞胶质细胞原性神经营养因子(GDNF)基因启动子Ⅰ区甲基化水平对其基因转录的影响。方法体外培养胶质瘤U251细胞,加入不同浓度5-氮杂胞苷(浓度分别为1、5、10和20μmol/L)干预,以加入PBS为对照。采用重亚硫酸盐测序法测定GDNF基因启动子Ⅰ区甲基化水平,RT-PCR检测GDNF m RNA的表达。结果与PBS组相比,1μmol/L 5-氮杂胞苷对GDNF基因启动子Ⅰ区甲基化水平无显著影响(P>0.05),5、10和20μmol/L 5-氮杂胞苷均显著降低其甲基化水平(P<0.05)。与PBS组相比,1μmol/L 5-氮杂胞苷对GDNF m RNA表达水平无显著影响(P>0.05),5μmol/L 5-氮杂胞苷显著增加其表达水平(P<0.05),但随着浓度进一步增加(10、20μmol/L),其表达水平逐渐降低。结论 5-氮杂胞苷对GDNF基因具有去甲基化作用;GDNF启动子Ⅰ区去甲基化能够增加GDNF基因的转录水平。 Objective To explore the effect of methylation levels of glia cell line-derived neurotroplic factor (GDNF) promoter I region on its transcription in glioma U251 cells. Methods The methylation levels of GDNF promoter I region were detected before and after intervention with different concentrations of 5-aza-CR in glioma U251 cells. The GDNF mRNA expression was detected by RT-PCR in each group. Results The methylation levels of GDNF gene promoter I region declined after the intervention with 5-aza-cR compared to the control group. The methylation levels of GDNF gene promoter I region were significantly lower in 5 μmol, 10 p, mol and 20μmol 5-aza-CR intervention groups than that in the control group (P〈0.05). The level of GDNF mRNA expression in U251 cells was significantly higher in the 5μmol 5-aza2CR intervention group than those in the control group and 1μmol, 10 μmol and 20 p, mol intervention groups (P〈0.05). There were insignificant differences in the levels of GDNF mRNA expression in U251 cells among the control group and 1μmol, 10μmol and 20μmol 5-aza-CR intervention groups (P〉0.05). Conclusion The demethylation of GDNF gene promoter [ region, which is produced by 5-aza-CR, may influence the expression of GDNF in U251 cell.
出处 《中国临床神经外科杂志》 2015年第7期410-412,共3页 Chinese Journal of Clinical Neurosurgery
关键词 胶质瘤 U251细胞 胶质细胞原性神经营养因子 启动子 甲基化 基因转录 Glioma GDNF U251 cells Promoter Methylation Expression
  • 相关文献

参考文献9

  • 1陈忠平.重视胶质瘤的规范化治疗[J].中国临床神经外科杂志,2007,12(5):257-258. 被引量:16
  • 2Egger G, Liang G, Aparicio A, et al. Epigenetics in human disease and prospects for epigenetic therapy [J]. Nature, 2004, 429(6990): 457-463.
  • 3Francois F. DNA methylation and histone modifications: teaming up to silence genes [J]. Curr Opin Genet Dev, 2005, 15(5): 490-495.
  • 4Howard G, Eiges R, Gaudet F, et al. Activation and transpo- sition of endogenous retroviral elements in hypomethylation induced tumors in mice [J]. Oncogene, 2008, 27(3): 404- 408.
  • 5Jones PA, Baylin SB. The epigenomics of cancer [J]. Cell, 2007, 128(4): 683 - 692.
  • 6Liang G, Lin JCY, Wei V, et al. Distinct localization of histone H3 acetylation and H3-K4 methylation to the trans- cription start sites in the human genome [J]. Proc Natl Acad Sci USA, 2004, 101(19): 7357-7362.
  • 7Bemstein BE, Meissner A, Lander ES. The mammalian epigenome [J]. Cell, 2007, 128(4): 669-681.
  • 8陈新军,袁先厚,江普查,马超,文志华.脑胶质瘤中hMLH1基因表达及启动子区的甲基化状态研究[J].中国临床神经外科杂志,2010,15(5):286-288. 被引量:2
  • 9赵庭生,徐培坤,朱立新.MGMT基因甲基化在胶质瘤化疗中的意义[J].中国临床神经外科杂志,2010,15(6):378-380. 被引量:4

二级参考文献23

  • 1Young-Jin Song,Hyo-Yung,Yun,Joo-Seung Park,Heon Kim.Effects of dietary intake and genetic factors on hypermethyiation of the hMLH1 gene promoter in gastric cancer[J].World Journal of Gastroenterology,2005,11(25):3834-3841. 被引量:19
  • 2胡苹,娄晋宁,章扬培,马雄君,赵奎明.MGMT在神经胶质瘤中表达的临床意义及联合应用STZ对愈后的影响[J].临床肿瘤学杂志,2006,11(1):19-22. 被引量:10
  • 3许洪升,张俊英,岳伟英,牟永告,张湘衡,赛克,陈忠平.脑胶质瘤MGMT表达与体外药敏相关性及其临床意义[J].中国临床神经外科杂志,2007,12(5):263-266. 被引量:8
  • 4Watatani M,Ikenaga M,Hatanaka T,et al.Analysis of MNNG-induced DNA damage in tumor cell strains from Japanese patients and demonstration of MNNG hypersensitivity of merxenografts in athymic nude mice[J].Carcinogenesis,1985,6:549-553.
  • 5Mollemann M,Wolter M,Felsberg J,et al.Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendrogliol tumors[J].Int J Cander,2005,113(3):379-385.
  • 6Hegi ME,Diser AC,Gorlia S,et al.MGMT gene silencing and benefit from temozolomide in glioblastoma[J].N Engl Med,2005,352(10):997-1003.
  • 7Day RS,Ziolkowaki CHJ,Scudiero DA,et al.Defective repair of alkylated DNA by human tumor and SV-40 transeformed human cell strains[J].Nature,1980,288:724-727.
  • 8Mineura K,Yanagisawa T,Wantanabe K,et al.Human brain tumor O6 -methylguanine-DNA methyltranseferase mRNA and its significance as indicator of selective chloroethylnitrosourea chemotherapy[J].Int J Cancer,1996,69:420-.
  • 9Ashby L,Larocca R,Ryken T.Treatment of brain tumor[J].N Engl Med,2005,352(22):2350-2353.
  • 10Chibbaro S,Benvenuti L,Caprio A,et al.Temozolomide as first line agent in treating high grade gliomas:phaseⅡstudy[J].J Neurooncol,2004,67(1):77-81.

共引文献19

同被引文献35

  • 1梁国刚,李毅,齐清会.大鼠小肠神经-Cajal间质细胞-平滑肌网络的超微结构研究[J].大连医科大学学报,2009,31(1):5-8. 被引量:7
  • 2Gabrio Bassotti,Vincenzo Villanacci,Dragos Cretoiu,Sanda Maria Cretoiu,Gabriel Becheanu.Cellular and molecular basis of chronic constipation: Taking the functional/idiopathic label out[J].World Journal of Gastroenterology,2013,19(26):4099-4105. 被引量:9
  • 3杜元灏,李晶,孙冬纬,刘维红,李桂平,林雪,任辉,王涵,邹蓓蕾,焦素林,黄卫.中国现代针灸病谱的研究[J].中国针灸,2007,27(5):373-378. 被引量:279
  • 4Kamachi Y, Uchikawa M, Kondoh H. Pairing SOX off: with partners in the regulation of embryonic development [J] Trends Genet, 2000, 16(4): 182-187.
  • 5Matsuoka J, Yashiro M, Sakurai K, et al. Role of the stem- ness factors sox2, oct3/4, and nanog in gastric carcinoma [J] J Surg Res, 2012, 174(1): 130-135.
  • 6Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system [J]. Acta Neuropathol, 2007, 114(2): 97-109.
  • 7Li AS, Siu MK, Zhang H, et al. Hypermethylation of SOX2 gene in hydatidiform mole and choriocarcinoma [J]. Reprod Sci, 2005, 15(7): 735-744.
  • 8Pevny LH, Nicolis SK. Sox2 roles in neural stem cells [J]. Int J Biochem Cell Biol, 2010, 42(3): 421-424.
  • 9Leis O, Eguiara A, Lopez-Arribillaga E, et al. Sox2 expres- sion in breast tumours and activation in breast cancer stem cells [J]. Oncogene, 2012, 31(11): 1354-1365.
  • 10Rudin CM, Durinck S, Stawiski EW, et al. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer [J]. Nat Genet, 2012, 44(10): 1111-1116.

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部